| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/14/2011 | CN101223171B Pharmacokinetically improved compounds |
| 09/14/2011 | CN101215297B Statin-diphosphonic acid conjugates, preparation method and application thereof |
| 09/14/2011 | CN101210012B Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof |
| 09/14/2011 | CN101194987B Powder medicament for treating recurrent mouth ulcer |
| 09/14/2011 | CN101184495B Methods, compositions, and formulations for preventing or reducing adverse effects in a patient |
| 09/14/2011 | CN101168050B Immunity regulating medicinal composition |
| 09/14/2011 | CN101163696B Histone deacetylase inhibitors |
| 09/14/2011 | CN101152200B Application of astilbin in preparing medicament for treating or preventing acute and chronic renal failure and renal fibrosis |
| 09/14/2011 | CN101087605B Medicine for the treatment or prevention of fibrotic diseases |
| 09/14/2011 | CN101087602B Use of L-carnitine and flucose for the treatment of cardiovascular diseases |
| 09/14/2011 | CN101084216B Inhibitors for the soluble epoxide hydrolase |
| 09/14/2011 | CN101019949B Qingkailing preparation for great transfusion and its preparation process |
| 09/14/2011 | CN101016312B Method of preparing powder phosphatide and lecithin for medicine and injection from soybean oil residue |
| 09/14/2011 | CN101015524B Coenzyme Q10 oral emulsion and preparing process thereof |
| 09/13/2011 | USRE42700 Induction of apoptosis in cancer cells |
| 09/13/2011 | US8019557 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/13/2011 | US8017809 Bisboron compound |
| 09/13/2011 | US8017783 Drugs for respiratory system disorders; also chemical intermediate for such drugs |
| 09/13/2011 | US8017781 Azaindazoles useful as inhibitors of kinases |
| 09/13/2011 | US8017779 Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| 09/13/2011 | US8017773 Cyclohexyl sulfonamide derivatives |
| 09/13/2011 | US8017771 Process for preparing acyclic HCV protease inhibitors |
| 09/13/2011 | US8017763 Chemically modified oligonucleotides |
| 09/13/2011 | US8017762 Modified iRNA agents |
| 09/13/2011 | US8017760 Antisense modulation of PTP1B expression |
| 09/13/2011 | US8017758 PNA oligomers, oligomer sets, methods and kits pertaining to the detection of Bacillus anthracis |
| 09/13/2011 | US8017739 Conjugates of hydroxyalkyl starch and a protein |
| 09/13/2011 | US8017733 Covalent attachment of hydrophilic polymers, such as polyalkylene glycol polymers, also known as polyalkylene oxides, to biologically-active molecules |
| 09/13/2011 | US8017657 Composition for the treatment and prevention of endothelial dysfunction |
| 09/13/2011 | US8017656 Organic sulfur compounds and use thereof |
| 09/13/2011 | US8017655 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 09/13/2011 | US8017654 Combination cancer therapy with bis(thiohydrazide) amide compounds |
| 09/13/2011 | US8017653 Bipolar trans carotenoid salts and their uses |
| 09/13/2011 | US8017652 Activators of peroxisome proliferator-activated receptors |
| 09/13/2011 | US8017651 Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia |
| 09/13/2011 | US8017650 treatment of dyslipidemia, associated, or not, to other metabolic disorders, such as glucose intolerance syndrome and type 1 or 2 diabetes mellitus |
| 09/13/2011 | US8017649 Flavonoid compounds and uses thereof |
| 09/13/2011 | US8017648 Methods of use of cyclopamine analogs |
| 09/13/2011 | US8017647 Crystalline sodium atorvastatin |
| 09/13/2011 | US8017646 e.g. 1-{3-[3-(3,4-dimethoxyphenyl)propoxy]propyl}pyrrolidine; neurodegenerative disorders, antidepressant, antidiabetic, hypotensive agent, cognition activator; |
| 09/13/2011 | US8017645 Melatonin daily dosage units |
| 09/13/2011 | US8017644 2-arylindole derivatives as nPGES-1 inhibitors |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017642 Functionally selective ALPHA2C adrenoreceptor agonists |
| 09/13/2011 | US8017641 P38 inhibitors and methods of use thereof |
| 09/13/2011 | US8017640 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 09/13/2011 | US8017639 Imidazole compounds |
| 09/13/2011 | US8017638 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1 |
| 09/13/2011 | US8017637 Inhibitors of cdc phosphatases |
| 09/13/2011 | US8017636 1,2,4-Oxadiazole benzoic acid compositions and their use in bioassays |
| 09/13/2011 | US8017635 Phenylalkyl substituted heteroaryl derivatives |
| 09/13/2011 | US8017634 Compositions for treating obesity and insulin resistance disorders |
| 09/13/2011 | US8017633 Administering [3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide; hypertension, hyperlipidemia, hyperuricemia, gout and hypercoagulability |
| 09/13/2011 | US8017632 Selective insecticides based on haloalkylnicotinic acid derivatives, anthranilic acid diamides, or phthalic acid diamides and safeners |
| 09/13/2011 | US8017631 Oxadiazole derivatives and their medical use |
| 09/13/2011 | US8017630 Cyclohexylacetic acid compounds |
| 09/13/2011 | US8017629 Compounds and uses thereof in modulating amyloid β |
| 09/13/2011 | US8017628 Pharmaceutically active sulfonyl hydrazide derivatives |
| 09/13/2011 | US8017627 Fentanyl composition for nasal administration |
| 09/13/2011 | US8017626 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 09/13/2011 | US8017625 Nitrogen-containing heteroaryl compounds and methods of use thereof |
| 09/13/2011 | US8017624 Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 09/13/2011 | US8017623 Dextromethorphan hydrochloride |
| 09/13/2011 | US8017622 Opioid and opioid-like compounds and uses thereof |
| 09/13/2011 | US8017621 Inhibitors of the mutant form of kit |
| 09/13/2011 | US8017620 Dutpase inhibitors |
| 09/13/2011 | US8017619 Compositions useful as inhibitors of protein kinases |
| 09/13/2011 | US8017618 Antifolate agent combinations in the treatment of cancer |
| 09/13/2011 | US8017617 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 09/13/2011 | US8017616 Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity |
| 09/13/2011 | US8017615 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2011 | US8017614 Arylindenopyrimidines compound and use as an adenosine A2a receptor antagonists |
| 09/13/2011 | US8017613 Beta-3 receptor ligands and their use in therapy |
| 09/13/2011 | US8017612 Piperazine compound and use thereof as a HCV polymerase inhibitor |
| 09/13/2011 | US8017611 Pyridine and pyrazine derivatives -083 |
| 09/13/2011 | US8017610 Phenylpyrrole derivative |
| 09/13/2011 | US8017609 Method for the prevention of thromboembolic disorders |
| 09/13/2011 | US8017608 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 09/13/2011 | US8017607 N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions |
| 09/13/2011 | US8017606 Therapy for bacteria infections other than Mycibacterium infections; antibiotic resistance |
| 09/13/2011 | US8017605 P38 kinase inhibiting agents |
| 09/13/2011 | US8017604 Imidazopyridines |
| 09/13/2011 | US8017603 Pyrimido [4,5-B]-oxazines for use as DGAT inhibitors |
| 09/13/2011 | US8017602 N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy |
| 09/13/2011 | US8017601 Bis-aryl kinase inhibitors and method |
| 09/13/2011 | US8017600 Imidazole compounds |
| 09/13/2011 | US8017599 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 09/13/2011 | US8017598 Compositions of R(+) and S(−) pramipexole and methods of using the same |
| 09/13/2011 | US8017597 Analgesic agent comprising cyclic phosphatidic acid derivative |
| 09/13/2011 | US8017596 Phosphonates useful as modulators of T-γ-9-δ-2 activity |
| 09/13/2011 | US8017595 Delivering therapeutic formulation containing N-sulphated-N,O-carboxymethylchitosan as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 09/13/2011 | US8017594 Agent against psychosocial stresses |
| 09/13/2011 | US8017592 RNAi-mediated inhibition of histamine receptor H1-related conditions |
| 09/13/2011 | US8017591 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals |
| 09/13/2011 | US8017590 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/13/2011 | US8017589 Avermectin B1 and avermectin B1 monosaccharide derivatives having an alkoxymethyl substituent in the 4″-or 4′-position |
| 09/13/2011 | US8017588 Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli |
| 09/13/2011 | US8017587 2-O- (β-D-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/13/2011 | US8017580 Therapies for chronic renal failure |
| 09/13/2011 | US8017574 identifying a Glucose-dependent Insulinotropic Peptide (GIP) secretagogue; G protein-coupled receptor (GPCR); useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis |